AR040692A1 - Polimorfo del dodecahidrociclopenta(a)fenantrenil ester del acido tiofenilcarboxilico - Google Patents
Polimorfo del dodecahidrociclopenta(a)fenantrenil ester del acido tiofenilcarboxilicoInfo
- Publication number
- AR040692A1 AR040692A1 AR20030102680A ARP030102680A AR040692A1 AR 040692 A1 AR040692 A1 AR 040692A1 AR 20030102680 A AR20030102680 A AR 20030102680A AR P030102680 A ARP030102680 A AR P030102680A AR 040692 A1 AR040692 A1 AR 040692A1
- Authority
- AR
- Argentina
- Prior art keywords
- ester
- crystal
- fenantrenil
- dodecahydrociclopenta
- polymorph
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J33/00—Normal steroids having a sulfur-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J33/00—Normal steroids having a sulfur-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
- C07J33/002—Normal steroids having a sulfur-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pulmonology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Steroid Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicinal Preparation (AREA)
Abstract
Formas de cristal polimorficas de (6S,9R,10S,11S,13S,16R,178R)-9-cloro-6-fluoro-11-hidroxi-17-metoxicarbonil-10,13,16-trimetil-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahidro-3H-ciclopenta[a]fenantren-17-iléster del ácido 3-metiltiofen-2-carboxílico. Las formas de cristal poseen actividad antiinflamatoria, y tienen muy buena estabilidad. También se describen métodos para preparar las formas de cristal. Reivindicación 1: Un compuesto de la fórmula (1) en una forma de cristal A que tiene un punto de fusión, mediante Calorimetría de Exploración Diferencial, de aproximadamente 264°C con descomposición simultánea, a una velocidad de calentamiento de 20°C/minuto, y las siguientes líneas de difracción características (2q en grados angulares +- 0,2°) en el patrón de difracción de rayos X del mismo: 3.6°, 7.3°, 13.4°, 14.6°, 18.3°, 22.0°, 25.8°, 25.9°, 29.5°, o en una forma de cristal B que tiene un punto de fusión, mediante Calorimetría de Exploración Diferencial, de aproximadamente 270°C con descomposición simultánea, a una velocidad de calentamiento de 20°C/minuto, y las siguientes líneas de difracción características (2q en grados angulares +- 0.2°) en el patrón de difracción de rayos X del mismo: 7.2°, 9.3°, 12.0°, 12.8°, 13.1°, 14.5°, 17.4°, 20.4°, 23.2°, y 25.8°.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0217504.0A GB0217504D0 (en) | 2002-07-29 | 2002-07-29 | Organic compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR040692A1 true AR040692A1 (es) | 2005-04-13 |
Family
ID=9941275
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AR20030102680A AR040692A1 (es) | 2002-07-29 | 2003-07-25 | Polimorfo del dodecahidrociclopenta(a)fenantrenil ester del acido tiofenilcarboxilico |
Country Status (30)
| Country | Link |
|---|---|
| US (1) | US7683048B2 (es) |
| EP (2) | EP1676854A1 (es) |
| JP (1) | JP2006501207A (es) |
| KR (1) | KR100688371B1 (es) |
| CN (1) | CN1305892C (es) |
| AR (1) | AR040692A1 (es) |
| AT (1) | ATE349459T1 (es) |
| AU (1) | AU2003251651B2 (es) |
| BR (1) | BR0313044A (es) |
| CA (1) | CA2493330C (es) |
| CY (1) | CY1106406T1 (es) |
| DE (1) | DE60310747T2 (es) |
| DK (1) | DK1554303T3 (es) |
| EC (1) | ECSP055579A (es) |
| ES (1) | ES2279970T3 (es) |
| GB (1) | GB0217504D0 (es) |
| HK (1) | HK1080484B (es) |
| IL (2) | IL166287A0 (es) |
| MX (1) | MXPA05001173A (es) |
| MY (1) | MY136407A (es) |
| NO (1) | NO20050806L (es) |
| NZ (2) | NZ537868A (es) |
| PE (1) | PE20040722A1 (es) |
| PL (1) | PL209409B1 (es) |
| PT (1) | PT1554303E (es) |
| RU (2) | RU2348646C1 (es) |
| SI (1) | SI1554303T1 (es) |
| TW (1) | TWI309164B (es) |
| WO (1) | WO2004013156A1 (es) |
| ZA (1) | ZA200500370B (es) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2389530B (en) | 2002-06-14 | 2007-01-10 | Cipla Ltd | Pharmaceutical compositions |
| GB0523654D0 (en) * | 2005-11-21 | 2005-12-28 | Novartis Ag | Organic compounds |
| GB0523656D0 (en) * | 2005-11-21 | 2005-12-28 | Novartis Ag | Organic compounds |
| GB0603783D0 (en) * | 2006-02-24 | 2006-04-05 | Novartis Ag | Organic compounds |
| JP2011513203A (ja) * | 2008-03-14 | 2011-04-28 | 大塚製薬株式会社 | Ｍｍｐ−２及び／又はｍｍｐ−９阻害剤 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SU550939A1 (ru) * | 1975-05-19 | 1994-07-15 | Институт химии древесины АН ЛатвССР | 1,2,3,4,4а,4в,5,6,10,10а -декагидро -6- хлорацетоксиметил -1,4а-диметил -7- (1-метилэтил) -1- фенантренкарбоновая кислота или ее соли |
| JPH08291073A (ja) * | 1995-04-22 | 1996-11-05 | Kissei Pharmaceut Co Ltd | 医薬品組成物及びその製造方法 |
| GB0015876D0 (en) * | 2000-06-28 | 2000-08-23 | Novartis Ag | Organic compounds |
-
2002
- 2002-07-29 GB GBGB0217504.0A patent/GB0217504D0/en not_active Ceased
-
2003
- 2003-07-25 AR AR20030102680A patent/AR040692A1/es unknown
- 2003-07-25 PE PE2003000741A patent/PE20040722A1/es not_active Application Discontinuation
- 2003-07-28 NZ NZ537868A patent/NZ537868A/en unknown
- 2003-07-28 EP EP06005390A patent/EP1676854A1/en not_active Withdrawn
- 2003-07-28 AT AT03766325T patent/ATE349459T1/de active
- 2003-07-28 DE DE60310747T patent/DE60310747T2/de not_active Expired - Lifetime
- 2003-07-28 BR BR0313044-4A patent/BR0313044A/pt not_active IP Right Cessation
- 2003-07-28 TW TW092120513A patent/TWI309164B/zh not_active IP Right Cessation
- 2003-07-28 NZ NZ549713A patent/NZ549713A/en unknown
- 2003-07-28 KR KR1020057001581A patent/KR100688371B1/ko not_active IP Right Cessation
- 2003-07-28 CA CA2493330A patent/CA2493330C/en not_active Expired - Fee Related
- 2003-07-28 AU AU2003251651A patent/AU2003251651B2/en not_active Ceased
- 2003-07-28 MY MYPI20032832A patent/MY136407A/en unknown
- 2003-07-28 CN CNB038180596A patent/CN1305892C/zh not_active Expired - Fee Related
- 2003-07-28 RU RU2007143025/04A patent/RU2348646C1/ru not_active IP Right Cessation
- 2003-07-28 PL PL373140A patent/PL209409B1/pl not_active IP Right Cessation
- 2003-07-28 WO PCT/EP2003/008314 patent/WO2004013156A1/en active Application Filing
- 2003-07-28 DK DK03766325T patent/DK1554303T3/da active
- 2003-07-28 RU RU2005105688/04A patent/RU2330043C2/ru not_active IP Right Cessation
- 2003-07-28 PT PT03766325T patent/PT1554303E/pt unknown
- 2003-07-28 JP JP2004525343A patent/JP2006501207A/ja active Pending
- 2003-07-28 MX MXPA05001173A patent/MXPA05001173A/es active IP Right Grant
- 2003-07-28 EP EP03766325A patent/EP1554303B1/en not_active Expired - Lifetime
- 2003-07-28 US US10/522,358 patent/US7683048B2/en not_active Expired - Fee Related
- 2003-07-28 ES ES03766325T patent/ES2279970T3/es not_active Expired - Lifetime
- 2003-07-28 SI SI200330721T patent/SI1554303T1/sl unknown
-
2005
- 2005-01-13 IL IL16628705A patent/IL166287A0/xx unknown
- 2005-01-14 ZA ZA200500370A patent/ZA200500370B/en unknown
- 2005-01-26 EC EC2005005579A patent/ECSP055579A/es unknown
- 2005-02-15 NO NO20050806A patent/NO20050806L/no unknown
-
2006
- 2006-01-05 HK HK06100247.5A patent/HK1080484B/zh not_active IP Right Cessation
-
2007
- 2007-03-22 CY CY20071100400T patent/CY1106406T1/el unknown
- 2007-07-26 IL IL184848A patent/IL184848A0/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP3126183B2 (ja) | 抗微生物剤、並びに置換２−シクロヘキサン−２−イル−アミン誘導体およびその製造法 | |
| TW200745111A (en) | New compounds | |
| AR052948A1 (es) | DERIVADOS DE ACETILENIL-PIRAZOLO-PIRIMIDINA COMO ANTAGONISTAS DE MGLUR2, METODOS PARA SU PREPARACION, COMPOSICIONES FARMACEUTICAS QUE LOS CONTIENEN Y SU EMPLEO EN LA FABRICACIoN DE UN MEDICAMENTO PARA EL TRATAMIENTO DE ENFERMEDADES DEL SNC | |
| GB0119249D0 (en) | Organic compounds | |
| WO2004014902A3 (en) | Compounds having an activity at metabotropic glutamate receptors | |
| AR034259A1 (es) | Polimorfos de un analogo de epotilona, procesos para prepararlos y las composiciones farmaceuticas que los contienen | |
| ATE440834T1 (de) | Substituierte arylaminderivate und verwendungsverfahren | |
| PE20061439A1 (es) | DERIVADOS DE 2-AMIDO-6-AMINO-8-OXO-PURINA COMO MODULADORES DEL RECEPTOR Toll (TLR) | |
| ES2108371T3 (es) | Nuevos derivados de estradieno de 11-benzaldoxima, procedimientos para su produccion y farmacos conteniendo estos compuestos. | |
| EP0522606A3 (en) | Pyridine derivatives, their production and use | |
| NZ596301A (en) | Novel 7-deazapurine nucleosides for therapeutic uses | |
| AR051754A1 (es) | Metodos para preparar compuestos de indazol | |
| TW200606164A (en) | New compounds | |
| MX2009010165A (es) | Nuevas imidazo[4,5-b]piridina-7-carboxamidas 704. | |
| ATE331713T1 (de) | Verfahren zur herstellung von 5-nitrobenzofuranen | |
| RU98108553A (ru) | Фармацевтические композиции, содержащие производные гидроксимикоевой кислоты | |
| ECSP045469A (es) | El uso de cianopirrolidinas sustituidas y preparaciones de combinacion que las contienen para tratar hiperlipidemia y enfermedades asociadas | |
| TW200800984A (en) | New compounds | |
| AR040692A1 (es) | Polimorfo del dodecahidrociclopenta(a)fenantrenil ester del acido tiofenilcarboxilico | |
| DK1594885T3 (da) | Lægemiddel til vækstinhibering af tumorer | |
| PA8581201A1 (es) | Nuevos derivados de tiazol | |
| SG145570A1 (en) | 4-æ7-halo-2-quino(xa-)linyloxy!phenoxy-propionic acid derivatives as antineoplastic agents | |
| ES2262459T1 (es) | Nuevas formas cristalinas de atorvastatina semicalcica y procedimientos para su preparacion. | |
| WO2006005611A3 (en) | Glucocorticoid 16alpha,17.alpha.-isoxazolidines as anti-inflammatory agents | |
| RU2009111389A (ru) | Полиморфная кристаллическая форма производного малеат индан-2-иламиногидроксиэтилхинолинона в качестве агониста бета-арецептора |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |